<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37457901</PMID><DateRevised><Year>2023</Year><Month>07</Month><Day>18</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2666-6065</ISSN><JournalIssue CitedMedium="Internet"><Volume>38</Volume><PubDate><Year>2023</Year><Month>Sep</Month></PubDate></JournalIssue><Title>The Lancet regional health. Western Pacific</Title><ISOAbbreviation>Lancet Reg Health West Pac</ISOAbbreviation></Journal><ArticleTitle>Post-COVID cognitive dysfunction: current status and research recommendations for high risk population.</ArticleTitle><Pagination><StartPage>100836</StartPage><MedlinePgn>100836</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">100836</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.lanwpc.2023.100836</ELocationID><Abstract><AbstractText>Post-COVID cognitive dysfunction (PCCD) is a condition in which patients with a history of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, usually three months from the onset, exhibit subsequent cognitive impairment in various cognitive domains, and cannot be explained by an alternative diagnosis. While our knowledge of the risk factors and management strategy of PCCD is still incomplete, it is necessary to integrate current epidemiology, diagnosis and treatment evidence, and form consensus criteria to better understand this disease to improve disease management. Identifying the risk factors and vulnerable population of PCCD and providing reliable strategies for effective prevention and management is urgently needed. In this paper, we reviewed epidemiology, diagnostic markers, risk factors and available treatments on the disease, formed research recommendation framework for vulnerable population, under the background of post-COVID period.</AbstractText><CopyrightInformation>&#xa9; 2023 The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Quan</LastName><ForeName>Meina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Medical Center for Neurological Disorders and National Clinical Research Center for Geriatric Diseases, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xuechu</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gong</LastName><ForeName>Min</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Qi</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Medical Center for Neurological Disorders and National Clinical Research Center for Geriatric Diseases, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jia</LastName><ForeName>Jianping</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Medical Center for Neurological Disorders and National Clinical Research Center for Geriatric Diseases, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Key Laboratory of Geriatric Cognitive Disorders, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Center for Neurodegenerative Disease and Memory Impairment, Capital Medical University, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center of Alzheimer's Disease, Beijing Institute of Brain Disorders, Collaborative Innovation Center for Brain Disorders, Capital Medical University, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Neurodegenerative Diseases, Ministry of Education, Beijing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lancet Reg Health West Pac</MedlineTA><NlmUniqueID>101774968</NlmUniqueID><ISSNLinking>2666-6065</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Diagnosis</Keyword><Keyword MajorTopicYN="N">Epidemiology</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Management</Keyword><Keyword MajorTopicYN="N">Post-COVID cognitive dysfunction</Keyword><Keyword MajorTopicYN="N">Risk factors</Keyword></KeywordList><CoiStatement>JJ received grants from the Key Project of the 10.13039/501100001809National Natural Science Foundation of China (U20A20354); Beijing Brain Initiative from Beijing Municipal Science &amp; Technology Commission (Z201100005520016, Z201100005520017); National major R&amp;D projects of China-Scientific technological innovation 2030 (2021ZD0201802); the 10.13039/501100012149National Key Scientific Instrument and Equipment Development Project (31627803); the Key Project of the National Natural Science Foundation of China (81530036). MQ received grants from Youth Program of National Natural Science Foundation of China (82101503) and 10.13039/501100005024Beijing Postdoctoral Research Foundation.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>5</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>17</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>17</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>17</Day><Hour>4</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>7</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37457901</ArticleId><ArticleId IdType="pmc">PMC10344681</ArticleId><ArticleId IdType="doi">10.1016/j.lanwpc.2023.100836</ArticleId><ArticleId IdType="pii">S2666-6065(23)00154-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gupta A., Madhavan M.V., Sehgal K., et al. Extrapulmonary manifestations of COVID-19. Nat Med. 2020;26(7):1017&#x2013;1032.</Citation><ArticleIdList><ArticleId IdType="pubmed">32651579</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G., Lee S., Alfaro-Almagro F., et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. 2022;604(7907):697&#x2013;707.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Alkodaymi M.S., Omrani O.A., Fawzy N.A., et al. Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis. Clin Microbiol Infect. 2022;28(5):657&#x2013;666.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8812092</ArticleId><ArticleId IdType="pubmed">35124265</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis A., Wamil M., Alberts J., et al. Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study. BMJ Open. 2021;11(3)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8727683</ArticleId><ArticleId IdType="pubmed">33785495</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano J.B., Murthy S., Marshall J.C., Relan P., Diaz J.V. A&#xa0;clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22(4):e102&#x2013;e107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601&#x2013;615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H., Raza S., Nowell J., Young M., Edison P. Long covid-mechanisms, risk factors, and management. BMJ. 2021;374:n1648.</Citation><ArticleIdList><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Monje M., Iwasaki A. The neurobiology of long COVID. Neuron. 2022;110(21):3484&#x2013;3496.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9537254</ArticleId><ArticleId IdType="pubmed">36288726</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-Castaneda A., Lu P., Geraghty A.C., et al. Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation. Cell. 2022;185(14):2452&#x2013;2468.e16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9189143</ArticleId><ArticleId IdType="pubmed">35768006</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang E.Y., Mao T., Klein J., et al. Diverse functional autoantibodies in patients with COVID-19. Nature. 2021;595(7866):283&#x2013;288.</Citation><ArticleIdList><ArticleId IdType="pubmed">34010947</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng M., Zhang S., Dong X., et al. COVID-19 associated EBV reactivation and effects of ganciclovir treatment. Immun Inflamm Dis. 2022;10(4):e597.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8959425</ArticleId><ArticleId IdType="pubmed">35349757</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu E., Xie Y., Al-Aly Z. Long-term neurologic outcomes of COVID-19. Nat Med. 2022;28(11):2406&#x2013;2415.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9671811</ArticleId><ArticleId IdType="pubmed">36138154</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandharipande P.P., Girard T.D., Jackson J.C., et al. Long-term cognitive impairment after critical illness. N&#xa0;Engl J Med. 2013;369(14):1306&#x2013;1316.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3922401</ArticleId><ArticleId IdType="pubmed">24088092</ArticleId></ArticleIdList></Reference><Reference><Citation>Thakur K.T., Miller E.H., Glendinning M.D., et al. COVID-19 neuropathology at Columbia University Irving Medical Center/New York Presbyterian Hospital. Brain. 2021;144(9):2696&#x2013;2708.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8083258</ArticleId><ArticleId IdType="pubmed">33856027</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban F., Ling S., Lui L.M.W., et al. Fatigue and cognitive impairment in Post-COVID-19 Syndrome: a systematic review and meta-analysis. Brain Behav Immun. 2022;101:93&#x2013;135.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8715665</ArticleId><ArticleId IdType="pubmed">34973396</ArticleId></ArticleIdList></Reference><Reference><Citation>Helms J., Kremer S., Merdji H., et al. Neurologic features in severe&#xa0;SARS-CoV-2 infection. N&#xa0;Engl J Med. 2020;382(23):2268&#x2013;2270.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7179967</ArticleId><ArticleId IdType="pubmed">32294339</ArticleId></ArticleIdList></Reference><Reference><Citation>Matias-Guiu J.A., Herrera E., Gonzalez-Nosti M., et al. Development of criteria for cognitive dysfunction in post-COVID syndrome: the IC-CoDi-COVID approach. Psychiatry Res. 2023;319</Citation><ArticleIdList><ArticleId IdType="pubmed">36521337</ArticleId></ArticleIdList></Reference><Reference><Citation>Hugon J., Msika E.F., Queneau M., Farid K., Paquet C. Long COVID: cognitive complaints (brain fog) and dysfunction of the cingulate cortex. J&#xa0;Neurol. 2022;269(1):44&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8211714</ArticleId><ArticleId IdType="pubmed">34143277</ArticleId></ArticleIdList></Reference><Reference><Citation>Premraj L., Kannapadi N.V., Briggs J., et al. Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: a meta-analysis. J&#xa0;Neurol Sci. 2022;434</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8798975</ArticleId><ArticleId IdType="pubmed">35121209</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimohata T. Neuro-COVID-19. Clin Exp Neuroimmunol. 2022;13(1):17&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8652810</ArticleId><ArticleId IdType="pubmed">34899999</ArticleId></ArticleIdList></Reference><Reference><Citation>Diez-Cirarda M., Yus M., Gomez-Ruiz N., et al. Multimodal neuroimaging in post-COVID syndrome and correlation with cognition. Brain. 2022;146:214.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9620345</ArticleId><ArticleId IdType="pubmed">36288544</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkataramani V., Winkler F. Cognitive deficits in long covid-19. N&#xa0;Engl J Med. 2022;387(19):1813&#x2013;1815.</Citation><ArticleIdList><ArticleId IdType="pubmed">36351274</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Sillett R., Zhu L., et al. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1,284,437 patients. Lancet Psychiatry. 2022;9:815.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9385200</ArticleId><ArticleId IdType="pubmed">35987197</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y.H., Chen Y., Wang Q.H., et al. One-year trajectory of cognitive changes in older survivors of COVID-19 in Wuhan, China: a longitudinal cohort study. JAMA Neurol. 2022;79(5):509&#x2013;517.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8905512</ArticleId><ArticleId IdType="pubmed">35258587</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng N., Zhao Y.M., Yan W., et al. A&#xa0;systematic review and meta-analysis of long term physical and mental sequelae of COVID-19 pandemic: call for research priority and action. Mol Psychiatry. 2023;28(1):423&#x2013;433.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9168643</ArticleId><ArticleId IdType="pubmed">35668159</ArticleId></ArticleIdList></Reference><Reference><Citation>Crivelli L., Palmer K., Calandri I., et al. Changes in cognitive functioning after COVID-19: a systematic review and meta-analysis. Alzheimers Dement. 2022;18(5):1047&#x2013;1066.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9073922</ArticleId><ArticleId IdType="pubmed">35297561</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker J.H., Lin J.J., Doernberg M., et al. Assessment of cognitive function in patients after COVID-19 infection. JAMA Netw Open. 2021;4(10)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8536953</ArticleId><ArticleId IdType="pubmed">34677597</ArticleId></ArticleIdList></Reference><Reference><Citation>Miskowiak K.W., Johnsen S., Sattler S.M., et al. Cognitive impairments four months after COVID-19 hospital discharge: pattern, severity and association with illness variables. Eur Neuropsychopharmacol. 2021;46:39&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8006192</ArticleId><ArticleId IdType="pubmed">33823427</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu W., Gauthier S., Jia J. Alzheimer's disease current status and perspective. Sci Bull. 2022;67:2494.</Citation><ArticleIdList><ArticleId IdType="pubmed">36604022</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C., Palacios-Ce&#xf1;a D., G&#xf3;mez-Mayordomo V., et al. Long-term post-COVID symptoms and associated risk factors in previously hospitalized patients: a multicenter study. J&#xa0;Infect. 2021;83(2):237&#x2013;279.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8110627</ArticleId><ArticleId IdType="pubmed">33984399</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y.H., Wang Y.R., Wang Q.H., et al. Post-infection cognitive impairments in a cohort of elderly patients with COVID-19. Mol Neurodegener. 2021;16(1):48.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8287105</ArticleId><ArticleId IdType="pubmed">34281568</ArticleId></ArticleIdList></Reference><Reference><Citation>Group P.C.C. Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study. Lancet Respir Med. 2022;10(8):761&#x2013;775.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9034855</ArticleId><ArticleId IdType="pubmed">35472304</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadi-Pooya A.A., Akbari A., Emami A., et al. Long COVID syndrome-associated brain fog. J&#xa0;Med Virol. 2022;94(3):979&#x2013;984.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8662118</ArticleId><ArticleId IdType="pubmed">34672377</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 rapid guideline: managing the long-term effects of COVID-19. National Institute for Health and Care Excellence (NICE); London: 2020.</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah W., Hillman T., Playford E.D., Hishmeh L. Managing the long term effects of covid-19: summary of NICE, SIGN, and RCGP rapid guideline. BMJ. 2021;372:n136.</Citation><ArticleIdList><ArticleId IdType="pubmed">33483331</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen E.L., Gossling A., Adam G., et al. Multi-organ assessment in mainly non-hospitalized individuals after SARS-CoV-2 infection: the Hamburg City Health Study COVID programme. Eur Heart J. 2022;43(11):1124&#x2013;1137.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8755397</ArticleId><ArticleId IdType="pubmed">34999762</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasreddine Z.S., Phillips N.A., Bedirian V., et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J&#xa0;Am Geriatr Soc. 2005;53(4):695&#x2013;699.</Citation><ArticleIdList><ArticleId IdType="pubmed">15817019</ArticleId></ArticleIdList></Reference><Reference><Citation>Blazhenets G., Schroeter N., Bormann T., et al. Slow but evident recovery from neocortical dysfunction and cognitive impairment in a series of chronic COVID-19 patients. J&#xa0;Nucl Med. 2021;62(7):910&#x2013;915.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8882885</ArticleId><ArticleId IdType="pubmed">33789937</ArticleId></ArticleIdList></Reference><Reference><Citation>Delgado-Alonso C., Valles-Salgado M., Delgado-Alvarez A., et al. Cognitive dysfunction associated with COVID-19: a comprehensive neuropsychological study. J&#xa0;Psychiatr Res. 2022;150:40&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8943429</ArticleId><ArticleId IdType="pubmed">35349797</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Sanchez C., Calabria M., Grunden N., et al. Neuropsychological deficits in patients with cognitive complaints after COVID-19. Brain Behav. 2022;12(3)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8933779</ArticleId><ArticleId IdType="pubmed">35137561</ArticleId></ArticleIdList></Reference><Reference><Citation>Whiteside D.M., Basso M.R., Naini S.M., et al. Outcomes in post-acute sequelae of COVID-19 (PASC) at 6 months post-infection Part 1: cognitive functioning. Clin Neuropsychol. 2022;36(4):806&#x2013;828.</Citation><ArticleIdList><ArticleId IdType="pubmed">35130818</ArticleId></ArticleIdList></Reference><Reference><Citation>Calabria M., Garcia-Sanchez C., Grunden N., et al. Post-COVID-19 fatigue: the contribution of cognitive and neuropsychiatric symptoms. J&#xa0;Neurol. 2022;269(8):3990&#x2013;3999.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9055007</ArticleId><ArticleId IdType="pubmed">35488918</ArticleId></ArticleIdList></Reference><Reference><Citation>He D., Yuan M., Dang W., et al. Long term neuropsychiatric consequences in COVID-19 survivors: cognitive impairment and inflammatory underpinnings fifteen months after discharge. Asian J Psychiatr. 2023;80</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9751007</ArticleId><ArticleId IdType="pubmed">36549172</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou H., Lu S., Chen J., et al. The landscape of cognitive function in recovered COVID-19 patients. J&#xa0;Psychiatr Res. 2020;129:98&#x2013;102.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7324344</ArticleId><ArticleId IdType="pubmed">32912598</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampshire A., Trender W., Chamberlain S.R., et al. Cognitive deficits in people who have recovered from COVID-19. eClinicalMedicine. 2021;39</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8298139</ArticleId><ArticleId IdType="pubmed">34316551</ArticleId></ArticleIdList></Reference><Reference><Citation>Frontera J.A., Boutajangout A., Masurkar A.V., et al. Comparison of serum neurodegenerative biomarkers among hospitalized COVID-19 patients versus non-COVID subjects with normal cognition, mild cognitive impairment, or Alzheimer's dementia. Alzheimers Dement. 2022;18(5):899&#x2013;910.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9011610</ArticleId><ArticleId IdType="pubmed">35023610</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosp J.A., Dressing A., Blazhenets G., et al. Cognitive impairment and altered cerebral glucose metabolism in the subacute stage of COVID-19. Brain. 2021;144(4):1263&#x2013;1276.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8083602</ArticleId><ArticleId IdType="pubmed">33822001</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Y., Li X., Geng D., et al. Cerebral micro-structural changes in COVID-19 patients&#x2013;an MRI-based 3-month follow-up study. eClinicalMedicine. 2020;25</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7396952</ArticleId><ArticleId IdType="pubmed">32838240</ArticleId></ArticleIdList></Reference><Reference><Citation>Caroli A., Capelli S., Napolitano A., et al. Brain diffusion alterations in patients with COVID-19 pathology and neurological manifestations. Neuroimage Clin. 2023;37</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9883079</ArticleId><ArticleId IdType="pubmed">36731251</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer P.T., Hellwig S., Blazhenets G., Hosp J.A. Molecular imaging findings on acute and long-term effects of COVID-19 on the brain: a systematic review. J&#xa0;Nucl Med. 2022;63(7):971&#x2013;980.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9258567</ArticleId><ArticleId IdType="pubmed">35177424</ArticleId></ArticleIdList></Reference><Reference><Citation>Jack C.R., Jr., Bennett D.A., Blennow K., et al. NIA-AA Research Framework: toward a biological definition of Alzheimer's disease. Alzheimers Dement. 2018;14(4):535&#x2013;562.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5958625</ArticleId><ArticleId IdType="pubmed">29653606</ArticleId></ArticleIdList></Reference><Reference><Citation>Thijssen E.H., La Joie R., Strom A., et al. Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study. Lancet Neurol. 2021;20(9):739&#x2013;752.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8711249</ArticleId><ArticleId IdType="pubmed">34418401</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman B., Cassar M.P., Tunnicliffe E.M., et al. Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge. eClinicalMedicine. 2021;31</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7808914</ArticleId><ArticleId IdType="pubmed">33490928</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortona E., Malorni W. Long COVID: to investigate immunological mechanisms and sex/gender related aspects as fundamental steps for tailored therapy. Eur Respir J. 2022;59(2)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8462012</ArticleId><ArticleId IdType="pubmed">34531277</ArticleId></ArticleIdList></Reference><Reference><Citation>Osmanov I.M., Spiridonova E., Bobkova P., et al. Risk factors for post-COVID-19 condition in previously hospitalised children using the ISARIC Global follow-up protocol: a prospective cohort study. Eur Respir J. 2022;59(2)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8576804</ArticleId><ArticleId IdType="pubmed">34210789</ArticleId></ArticleIdList></Reference><Reference><Citation>Almeida-Meza P., Steptoe A., Cadar D. Markers of cognitive reserve and dementia incidence in the English Longitudinal Study of Ageing. Br J Psychiatry. 2021;218(5):243&#x2013;251.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7529639</ArticleId><ArticleId IdType="pubmed">32223764</ArticleId></ArticleIdList></Reference><Reference><Citation>Politi J., Mart&#xed;n-S&#xe1;nchez M., Mercuriali L., et al. Epidemiological characteristics and outcomes of COVID-19 cases: mortality inequalities by socio-economic status, Barcelona, Spain, 24 February to 4 May 2020. Euro Surveill. 2021;26(20)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8138960</ArticleId><ArticleId IdType="pubmed">34018483</ArticleId></ArticleIdList></Reference><Reference><Citation>Baig A.M., Khaleeq A., Ali U., Syeda H. Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms. ACS Chem Neurosci. 2020;11(7):995&#x2013;998.</Citation><ArticleIdList><ArticleId IdType="pubmed">32167747</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y.C., Bai W.Z., Hashikawa T. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J&#xa0;Med Virol. 2020;92(6):552&#x2013;555.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7228394</ArticleId><ArticleId IdType="pubmed">32104915</ArticleId></ArticleIdList></Reference><Reference><Citation>Steardo L., Steardo L., Jr., Zorec R., Verkhratsky A. Neuroinfection may contribute to pathophysiology and clinical manifestations of COVID-19. Acta Physiol. 2020;229(3)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7228251</ArticleId><ArticleId IdType="pubmed">32223077</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo C.L., Pilling L.C., Atkins J.L., et al. APOE e4 Genotype Predicts Severe COVID-19 in the UK Biobank Community Cohort. J&#xa0;Gerontol A Biol Sci Med Sci. 2020;75(11):2231&#x2013;2232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7314139</ArticleId><ArticleId IdType="pubmed">32451547</ArticleId></ArticleIdList></Reference><Reference><Citation>Ostendorf B.N., Patel M.A., Bilanovic J., et al. Common human genetic variants of APOE impact murine COVID-19 mortality. Nature. 2022;611(7935):346&#x2013;351.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10957240</ArticleId><ArticleId IdType="pubmed">36130725</ArticleId></ArticleIdList></Reference><Reference><Citation>Montagne A., Nation D.A., Sagare A.P., et al. APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline. Nature. 2020;581(7806):71&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7250000</ArticleId><ArticleId IdType="pubmed">32376954</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurki S.N., Kantonen J., Kaivola K., et al. APOE epsilon4 associates with increased risk of severe COVID-19, cerebral microhaemorrhages and post-COVID mental fatigue: a Finnish biobank, autopsy and clinical study. Acta Neuropathol Commun. 2021;9(1):199.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8696243</ArticleId><ArticleId IdType="pubmed">34949230</ArticleId></ArticleIdList></Reference><Reference><Citation>Yazdanpanah N., Rezaei N. Autoimmune complications of COVID-19. J&#xa0;Med Virol. 2022;94(1):54&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8661629</ArticleId><ArticleId IdType="pubmed">34427929</ArticleId></ArticleIdList></Reference><Reference><Citation>Izcovich A., Siemieniuk R.A., Bartoszko J.J., et al. Adverse effects of remdesivir, hydroxychloroquine and lopinavir/ritonavir when used for COVID-19: systematic review and meta-analysis of randomised trials. BMJ Open. 2022;12(3)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8895418</ArticleId><ArticleId IdType="pubmed">35236729</ArticleId></ArticleIdList></Reference><Reference><Citation>Borah P., Deb P.K., Chandrasekaran B., et al. Neurological consequences of SARS-CoV-2 infection and concurrence of treatment-induced neuropsychiatric adverse events in COVID-19 patients: navigating the uncharted. Front Mol Biosci. 2021;8</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7930836</ArticleId><ArticleId IdType="pubmed">33681293</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotfis K., van Diem-Zaal I., Williams Roberson S., et al. The future of intensive care: delirium should no longer be an issue. Crit Care. 2022;26(1):200.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9254432</ArticleId><ArticleId IdType="pubmed">35790979</ArticleId></ArticleIdList></Reference><Reference><Citation>Neelamegam M., Zgibor J., Chen H., et al. The effect of opioids on the cognitive function of older adults: results from the Personality and Total Health through life study. Age Ageing. 2021;50(5):1699&#x2013;1708.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8437064</ArticleId><ArticleId IdType="pubmed">33755047</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar A., Chattopadhyay A., Gupta S. Neuropsychiatric manifestation of the drugs used in the treatment of SARS-2-CoV-2019 (COVID-19) infection and their management: an overview and practice implications. Asian J Psychiatr. 2022;73</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8986230</ArticleId><ArticleId IdType="pubmed">35461033</ArticleId></ArticleIdList></Reference><Reference><Citation>Levaillant M., Wathelet M., Lamer A., Riquin E., Gohier B., Hamel-Broza J.F. Impact of COVID-19 pandemic and lockdowns on the consumption of anxiolytics, hypnotics and antidepressants according to age groups: a French nationwide study. Psychol Med. 2021:1&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8692848</ArticleId><ArticleId IdType="pubmed">34904556</ArticleId></ArticleIdList></Reference><Reference><Citation>Velayudhan L., Aarsland D., Ballard C. Mental health of people living with dementia in care homes during COVID-19 pandemic. Int Psychogeriatr. 2020;32(10):1253&#x2013;1254.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7302947</ArticleId><ArticleId IdType="pubmed">32487278</ArticleId></ArticleIdList></Reference><Reference><Citation>Simonetti A., Pais C., Jones M., et al. Neuropsychiatric symptoms in elderly with dementia during COVID-19 pandemic: definition, treatment, and future directions. Front Psychiatry. 2020;11</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7550649</ArticleId><ArticleId IdType="pubmed">33132939</ArticleId></ArticleIdList></Reference><Reference><Citation>Manca R., De Marco M., Venneri A. The impact of COVID-19 infection and enforced prolonged social isolation on neuropsychiatric symptoms in older adults with and without dementia: a review. Front Psychiatry. 2020;11</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7649825</ArticleId><ArticleId IdType="pubmed">33192732</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Z.C., Liu S., Gan J., et al. The impact of the COVID-19 pandemic and lockdown on mild cognitive impairment, Alzheimer's disease and dementia with Lewy bodies in China: a 1-year follow-up study. Front Psychiatry. 2021;12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8355429</ArticleId><ArticleId IdType="pubmed">34393864</ArticleId></ArticleIdList></Reference><Reference><Citation>Bethell J., Aelick K., Babineau J., et al. Social connection in long-term care homes: a scoping review of published research on the mental health impacts and potential strategies during COVID-19. J&#xa0;Am Med Dir Assoc. 2021;22(2):228&#x2013;237.e25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9186333</ArticleId><ArticleId IdType="pubmed">33347846</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou J., Liu C., Sun Y., Huang W., Ye K. Cognitive disorders associated with hospitalization of COVID-19: results from an observational cohort study. Brain Behav Immun. 2021;91:383&#x2013;392.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7584518</ArticleId><ArticleId IdType="pubmed">33148439</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H., Li T., Barbarino P., et al. Dementia care during COVID-19. Lancet. 2020;395(10231):1190&#x2013;1191.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7146671</ArticleId><ArticleId IdType="pubmed">32240625</ArticleId></ArticleIdList></Reference><Reference><Citation>Williamson E.J., Walker A.J., Bhaskaran K., et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584(7821):430&#x2013;436.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611074</ArticleId><ArticleId IdType="pubmed">32640463</ArticleId></ArticleIdList></Reference><Reference><Citation>Godeau D., Petit A., Richard I., Roquelaure Y., Descatha A. Return-to-work, disabilities and occupational health in the age of COVID-19. Scand J Work Environ Health. 2021;47(5):408&#x2013;409.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8259700</ArticleId><ArticleId IdType="pubmed">34003294</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers J.P., Chesney E., Oliver D., et al. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry. 2020;7(7):611&#x2013;627.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7234781</ArticleId><ArticleId IdType="pubmed">32437679</ArticleId></ArticleIdList></Reference><Reference><Citation>Vindegaard N., Benros M.E. COVID-19 pandemic and mental health consequences: systematic review of the current evidence. Brain Behav Immun. 2020;89:531&#x2013;542.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7260522</ArticleId><ArticleId IdType="pubmed">32485289</ArticleId></ArticleIdList></Reference><Reference><Citation>Ward C.F., Figiel G.S., McDonald W.M. Altered mental status as a novel initial clinical presentation for COVID-19 infection in the elderly. Am J Geriatr Psychiatry. 2020;28(8):808&#x2013;811.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7227566</ArticleId><ArticleId IdType="pubmed">32425470</ArticleId></ArticleIdList></Reference><Reference><Citation>Nehme M., Braillard O., Salamun J., et al. Symptoms after COVID-19 vaccination in patients with post-acute sequelae of SARS-CoV-2. J&#xa0;Gen Intern Med. 2022;37(6):1585&#x2013;1588.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8863092</ArticleId><ArticleId IdType="pubmed">35194744</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao P., Liu J., Liu M. Effect of COVID-19 vaccines on reducing the risk of long COVID in the real world: a systematic review and meta-analysis. Int J Environ Res Public Health. 2022;19(19)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9566528</ArticleId><ArticleId IdType="pubmed">36231717</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall M. The four most urgent questions about long COVID. Nature. 2021;594(7862):168&#x2013;170.</Citation><ArticleIdList><ArticleId IdType="pubmed">34108700</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q., Mak J.W.Y., Su Q., et al. Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome. Gut. 2022;71(3):544&#x2013;552.</Citation><ArticleIdList><ArticleId IdType="pubmed">35082169</ArticleId></ArticleIdList></Reference><Reference><Citation>Ancona G., Alagna L., Alteri C., et al. Gut and airway microbiota dysbiosis and their role in COVID-19 and long-COVID. Front Immunol. 2023;14</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10030519</ArticleId><ArticleId IdType="pubmed">36969243</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia L., Quan M., Fu Y., et al. Dementia in China: epidemiology, clinical management, and research advances. Lancet Neurol. 2020;19(1):81&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">31494009</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonilla H., Peluso M.J., Rodgers K., et al. Therapeutic trials for long COVID-19: a call to action from the interventions taskforce of the RECOVER initiative. Front Immunol. 2023;14</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10034329</ArticleId><ArticleId IdType="pubmed">36969241</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides T.C., Cholevas C., Polyzoidis K., Politis A. Long-COVID syndrome-associated brain fog and chemofog: luteolin to the rescue. Biofactors. 2021;47(2):232&#x2013;241.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8250989</ArticleId><ArticleId IdType="pubmed">33847020</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang Y., Xing Y., Zhu Z., et al. The effects of 7-week cognitive training in patients with vascular cognitive impairment, no dementia (the Cog-VACCINE study): a randomized controlled trial. Alzheimers Dement. 2019;15(5):605&#x2013;614.</Citation><ArticleIdList><ArticleId IdType="pubmed">30894299</ArticleId></ArticleIdList></Reference><Reference><Citation>Sikkes S.A.M., Tang Y., Jutten R.J., et al. Toward a theory-based specification of non-pharmacological treatments in aging and dementia: focused reviews and methodological recommendations. Alzheimers Dement. 2021;17(2):255&#x2013;270.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7970750</ArticleId><ArticleId IdType="pubmed">33215876</ArticleId></ArticleIdList></Reference><Reference><Citation>Society PaMHBoCG, Association AsDBoCEHC, Association GPGoPBoCM, Association GPWGoPAoCMD, Health PCoMHftEoCAoM Expert advice on mental health and psychosocial support for patients with cognitive impairment and their caregivers during the prevention and control of COVID-19. Chin J Psychiatr. 2020;53(2):89&#x2013;94.</Citation></Reference><Reference><Citation>Jung A.R., Kim D., Park E.A. Cognitive intervention using information and communication Technology for older adults with mild cognitive impairment: a systematic review and meta-analysis. Int J Environ Res Public Health. 2021;18(21)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8583509</ArticleId><ArticleId IdType="pubmed">34770049</ArticleId></ArticleIdList></Reference><Reference><Citation>Cicerone K.D., Goldin Y., Ganci K., et al. Evidence-based cognitive rehabilitation: systematic review of the literature from 2009 through 2014. Arch Phys Med Rehabil. 2019;100(8):1515&#x2013;1533.</Citation><ArticleIdList><ArticleId IdType="pubmed">30926291</ArticleId></ArticleIdList></Reference><Reference><Citation>Santana K., Franca E., Sato J., et al. Non-invasive brain stimulation for fatigue in post-acute sequelae of SARS-CoV-2 (PASC) Brain Stimul. 2023;16(1):100&#x2013;107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9867562</ArticleId><ArticleId IdType="pubmed">36693536</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliver-Mas S., Delgado-Alonso C., Delgado-Alvarez A., et al. Transcranial direct current stimulation for post-COVID fatigue: a randomized, double-blind, controlled pilot study. Brain Commun. 2023;5(2):fcad117.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10116605</ArticleId><ArticleId IdType="pubmed">37091591</ArticleId></ArticleIdList></Reference><Reference><Citation>Thams F., Antonenko D., Fleischmann R., et al. Neuromodulation through brain stimulation-assisted cognitive training in patients with post-COVID-19 cognitive impairment (Neuromod-COV): study protocol for a PROBE phase IIb trial. BMJ Open. 2022;12(4)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9002255</ArticleId><ArticleId IdType="pubmed">35410927</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung T., Ho Y.S., Yeung J.W., et al. Effects of transcranial pulse stimulation (TPS) on young adults with symptom of depression: a pilot randomised controlled trial protocol. Front Neurol. 2022;13</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8990306</ArticleId><ArticleId IdType="pubmed">35401418</ArticleId></ArticleIdList></Reference><Reference><Citation>Jimenez-Pavon D., Carbonell-Baeza A., Lavie C.J. Physical exercise as therapy to fight against the mental and physical consequences of COVID-19 quarantine: special focus in older people. Prog Cardiovasc Dis. 2020;63(3):386&#x2013;388.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7118448</ArticleId><ArticleId IdType="pubmed">32220590</ArticleId></ArticleIdList></Reference><Reference><Citation>Angelidi A.M., Kokkinos A., Katechaki E., Ros E., Mantzoros C.S. Mediterranean diet as a nutritional approach for COVID-19. Metabolism. 2021;114</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833284</ArticleId><ArticleId IdType="pubmed">33080270</ArticleId></ArticleIdList></Reference><Reference><Citation>Jolliffe D.A., Camargo C.J., Sluyter J.D., et al. Vitamin D supplementation to prevent acute respiratory infections: a systematic review and meta-analysis of aggregate data from randomised controlled trials. Lancet Diabetes Endocrinol. 2021;9(5):276&#x2013;292.</Citation><ArticleIdList><ArticleId IdType="pubmed">33798465</ArticleId></ArticleIdList></Reference><Reference><Citation>Altena E., Baglioni C., Espie C.A., et al. Dealing with sleep problems during home confinement due to the COVID-19 outbreak: practical recommendations from a task force of the European CBT-I Academy. J&#xa0;Sleep Res. 2020;29(4)</Citation><ArticleIdList><ArticleId IdType="pubmed">32246787</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngandu T., Lehtisalo J., Solomon A., et al. A&#xa0;2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. Lancet. 2015;385(9984):2255&#x2013;2263.</Citation><ArticleIdList><ArticleId IdType="pubmed">25771249</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia J., Zhao T., Liu Z., et al. Association between healthy lifestyle and memory decline in older adults: 10 year, population based, prospective cohort study. BMJ. 2023;380</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9872850</ArticleId><ArticleId IdType="pubmed">36696990</ArticleId></ArticleIdList></Reference><Reference><Citation>Expert Group CIaDCoCMDA. Jia J.P. Consensus on diagnosis, treatment and management of cognitive impairment after COVID-19. Sci Sin Vitae. 2022;52(12):1905&#x2013;1914.</Citation></Reference><Reference><Citation>Jia J.P., Gong M. ["Cognitive unit" is a diagnosis and treatment pattern suitable for the clinical practice of cognitive disorders in China] Zhonghua Yi Xue Za Zhi. 2020;100(9):645&#x2013;647.</Citation><ArticleIdList><ArticleId IdType="pubmed">32187908</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiyegbusi O.L., Hughes S.E., Turner G., et al. Symptoms, complications and management of long COVID: a review. J&#xa0;R Soc Med. 2021;114(9):428&#x2013;442.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8450986</ArticleId><ArticleId IdType="pubmed">34265229</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>